Novo Nordisk

Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to front of pharma's growth pack in Q2
Fierce Pharma
Wed, 08/16/23 - 10:05 am
Novo Nordisk
Eli Lilly
obesity
diabetes
earnings
Novo Nordisk prolongs rationing Wegovy solutions
Beckers Hospital Review
Thu, 08/10/23 - 09:59 pm
Novo Nordisk
Wegovy
drug rationing
drug shortages
Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline
Fierce Biotech
Thu, 08/10/23 - 11:41 am
Novo Nordisk
M&A
obesity
Inversago
In the era of blockbuster obesity drugs, a personalized approach could boost outcomes
Pharma Voice
Wed, 08/9/23 - 10:14 am
obesity
Phenomix
Novo Nordisk
Ozempic
Wegovy
Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy
Fierce Pharma
Tue, 08/8/23 - 11:25 am
Novo Nordisk
Wegovy
clinical trials
cardiovascular disease
obesity
Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance
MedCity News
Mon, 08/7/23 - 11:12 pm
insurance
weight loss
payers
Novo Nordisk
Eli Lilly
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines
Fierce Pharma
Thu, 08/3/23 - 06:44 pm
Novo Nordisk
Eli Lilly
Mounjaro
Ozempic
legal
side effects
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
NASH
Boehringer Ingelheim
Zealand Pharma
Akero Therapeutics
Axcella Health
Eli Lilly
Pfizer
Ionis Pharmaceuticals
Cascade
AstraZeneca
Gilead Sciences
Novo Nordisk
Ascletis Pharma
MediciNova
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Motley Fool
Wed, 08/2/23 - 10:16 am
Ozempic
Novo Nordisk
weight loss
diabetes
Why Novo Nordisk Stock Thrashed the Market on Monday
Motley Fool
Mon, 07/31/23 - 09:52 pm
Novo Nordisk
Ozempic
share repurchase
Stomachs freeze up with Ozempic in rare side effect
Beckers Hospital Review
Wed, 07/26/23 - 09:54 am
Novo Nordisk
Ozempic
side effects
gastroparesis
New weight loss drugs carry high price tags and lots of questions for seniors
Medical Marketing and Media
Tue, 07/25/23 - 08:53 pm
Seniors
Wegovy
Novo Nordisk
Mounjaro
Eli Lilly
weight loss
Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare
Fierce Pharma
Thu, 07/20/23 - 09:42 pm
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
obesity
Novo Nordisk turns RNAi research up to Eleven with new biotech pact
Fierce Biotech
Mon, 07/17/23 - 08:53 am
Novo Nordisk
RNA
Eleven Biotherapeutics
Why Novo Nordisk Stock Flew Higher on Friday
Motley Fool
Sun, 07/16/23 - 02:59 pm
Novo Nordisk
Wegovy
Pharma finds a way to gain weight
EP Vantage
Thu, 07/13/23 - 09:49 am
obesity
Eli Lilly
Novo Nordisk
Wegovy
Mounjaro
Why Novo Nordisk Stock Sank on Tuesday
Motley Fool
Tue, 07/11/23 - 11:23 pm
Novo Nordisk
obesity
Wegovy
European regulators probe suicide risk to Ozempic, other Novo drug Saxenda
BioPharma Dive
Mon, 07/10/23 - 09:40 pm
Novo Nordisk
Ozempic
Saxenda
EMA
Europe
suicide
Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher
Motley Fool
Thu, 07/6/23 - 11:17 am
Novo Nordisk
Ozempic
obesity
diabetes
weight loss
addiction

Pages